Comparison of clinical effects of Jing Wan Hong ointment and nano silver gel in treating diabetic foot ulcer

doi:10.3877/cma.j.issn.1673-9450.2018.06.011

Abstract

Abstract:

Objective

To compare the efficacy of Jing Wan Hong ointment and nano silver gel in treating patients with diabetic foot ulcer by random and control methods.

Methods

All patients were treated in Guangdong General Hospital (Guangdong Academy of Medical Sciences) from July 2015 to May 2018. Ninty-six patients with diabetic foot ulcer were divided into 48 cases of Jing Wan Hong oinment group and 48 cases of nano silver gel group according to random comparison table method. The two groups were treated with Jing Wan Hong ointment or nano silver gel. The topical medicine was 3 mm thick, dressing every other day. The wound healed at any time within 16 weeks, and the study was completed. Visual analogue score (VAS), healing cases, healing time, pulse, heart rate, blood pressure and other vital signs were compared between the two groups at 4th, 8th, 12th and 16th weeks after treatment. Data were processed with χ² test and t text.

Results

The VAS score of Jing Wan Hong ointment group [(3.09±1.08) points] was significantly lower than that of nano silver gel group [(5.83± 1.15) points], and the difference was statistically significant (t=28.25, P<0.05). There was no difference in healing cases between Jing Wan Hong ointment group and nano silver gel group at 8th, 12th and 16th week (χ²=0.26, 0.71, 0.26; P=0.77, 0.45, 0.77). The healing time of Jing Wan Hong ointment group was (72.6 ±16.2) d, and that of nano silver gel group was (69.8±21.3) d, there was no significant difference in healing time between the two groups (t=0.37, P=0.71). There was no abnormal change in respiratory rate, heart rate and blood pressure in the two groups.

Conclusions

Jing Wan Hong ointment and nano silver gel both can promote the healing of diabetic foot ulcer. Jing Wan Hong ointment has less pain and more comfortable treatment than nano silver gel.

Key words: Diabetic foot, Ulcer, Comparative effectiveness research, Jing Wan Hong ointment, Nano silver gel

Zhifeng Huang, Shaoyi Zheng, Wen Lai, Bing Xiong, Zu′an Liu, Hanhua Li, Chuanwei Sun, Lianghua Ma, Hongmin Luo. Comparison of clinical effects of Jing Wan Hong ointment and nano silver gel in treating diabetic foot ulcer[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2018, 13(06): 455-458.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2018.06.011

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2018/V13/I06/455

Figures/Tables 2

References 25

[1]	Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12):1009-1011.
[2]	陈煜. 磺胺嘧啶银的研究进展[J]. 中国现代药物应用，2013, 7(23):224-225.
[3]	冉兴无，杨兵全，许樟荣. 我国糖尿病足病的诊治现状与未来的研究方向[J]. 中华糖尿病杂志，2014, 6(7):437-439.
[4]	Fu X, Sheng Z, Cherry GW, et al. Epidemiological study of chronic dermal ulcers in China[J]. Wound Repair Regen, 1998, 6(1):21-27.
[5]	Jiang Y, Huang S, Fu X, et al. Epidemiology of chronic cutaneous wounds in China[J]. Wound Repair Regen, 2011, 19(2):181-188.
[6]	付小兵. 糖尿病足及下肢慢性创面修复[M]. 北京：人民军医出版社，2011: 3-25.
[7]	舒斌，祁少海. 糖尿病足临床研究进展[J/CD]. 中华损伤与修复杂志(电子版), 2010, 5(2):243-248.
[8]	Tomita M, Kabeya Y, Okisugi M, et al. Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot Ulcer[J]. J Diabetes Res, 2016, 2016:5938540.
[9]	Pichu S, Vimalraj S, Sathiyamoorthy J, et al. Association of hypoxia inducible factor-1 alpha exon 12 mutation in diabetic patients with and without diabetic foot ulcer[J]. Int J Biol Macromol, 2018, 119:833-837.
[10]	黄志锋，郑少逸，赖文，等. 大网膜轴型瓣转移修复胸部难愈创面的临床效果[J]. 中华烧伤杂志，2016, 32(7):429-431.
[11]	Jeffcoate W, Barron E, Lomas J, et al. Using data to tackle the burden of amputation in diabetes[J]. Lancet, 2017, 390(10105):e29-e30.
[12]	Brennan MB, Hess TM, Bartle B, et al. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes[J]. J Diabetes Complications, 2017, 31(3):556-561.
[13]	Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study[J]. Diabet Med, 2018, 35(1):78-88.
[14]	姜玉峰，黄沙，邹吉平，等. 京万红软膏治疗糖尿病慢性创面的实验研究[J]. 感染、炎症、修复，2013, 14(1):34-37.
[15]	Kateel R, Augustine AJ, Prabhu S, et al. Clinical and microbiological profile of diabetic foot ulcer patients in a tertiary care hospital[J]. Diabetes Metab Syndr, 2018, 12(1):27-30.
[16]	DiDomenico LA, Orgill DP, Galiano RD, et al. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients[J]. Int Wound J, 2018.
[17]	Mohamed H, EI Lenjawi B, Abu Salma M, et al. Honey based therapy for the management of a recalcitrant diabetic foot ulcer[J]. J Tissue Viability, 2014, 23(1):29-33.
[18]	买建修，杨会举，刘国平. 湿性愈合与煨脓生肌相关性探析[J]. 辽宁中医杂志，2012, 39(9):1730-1732.
[19]	丁雄飞. 马应龙痔疮膏联合京万红软膏治疗糖尿病足22例[J]. 中医外治杂志，2009, 18(4):18-19.
[20]	Jin S, Zhang M, Gao Y, et al. The efficacy of Jing Wan Hong Ointment for nerve injury diabetic foot ulcer and its mechanisms[J]. J Diabetes Res, 2014, 2014:259412.
[21]	姜玉峰，付小兵，陆树良，等. 中国人群体表慢性难愈合创面病原微生物学特征分析[J]. 感染、炎症、修复，2011, 12(3):134-138.
[22]	宋民宪，杨明. 新编国家中成药[M]. 2版. 北京：人民卫生出版社，2011: 419.
[23]	袁汀. 紫草制剂治疗烧烫伤研究进展[J]. 实用药物与临床，2011, 14(5):423-425.
[24]	庄江能. 大黄的主要成分及其临床药理研究进展[J]. 西南军医，2009, 11(5):931-933.
[25]	姜玉峰，许樟荣，陆树良，等. 多中心完全随机、标准治疗平行对照评价京万红软膏治疗糖尿病足慢性创面的临床研究[J]. 感染、炎症、修复，2015, 16(1):33-36.

组别	例数	性别(例)		年龄(岁，±s)	创面大小(cm², ±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
组别	例数	男	女	年龄(岁，±s)	创面大小(cm², ±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
京万红软膏组	48	26	22	70.2±12.3	15.7±5.3	8.3±2.2	7.9±2.8
纳米银离子组	48	25	23	68.8±14.3	16.0±6.3	7.9±1.7	8.1±2.4
χ²值	?	0.04		?	?	?	?
t值	?	?	?	0.37	0.40	0.25	0.41
P值	?	0.84		0.71	0.69	0.81	0.68

组别	例数	性别(例)		年龄(岁，±s)	创面大小(cm², ±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
组别	例数	男	女	年龄(岁，±s)	创面大小(cm², ±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
京万红软膏组	48	26	22	70.2±12.3	15.7±5.3	8.3±2.2	7.9±2.8
纳米银离子组	48	25	23	68.8±14.3	16.0±6.3	7.9±1.7	8.1±2.4
χ²值	?	0.04		?	?	?	?
t值	?	?	?	0.37	0.40	0.25	0.41
P值	?	0.84		0.71	0.69	0.81	0.68

组别	例数	VAS(分，±s)	愈合情况(例数)				平均愈合时间(d, ±s)
组别	例数	VAS(分，±s)	第4周	第8周	第12周	第16周	平均愈合时间(d, ±s)
京万红软膏组	48	3.09±1.08	0	3	32	45	72.6±16.2
纳米银离子组	48	5.83±1.15	0	1	28	47	69.8±21.3
χ²值	?	?	?	0.26	0.71	0.26	?
t值	?	28.25	?	?	?	?	0.37
P值	?	<0.05	?	0.77	0.45	0.77	0.71

组别	例数	VAS(分，±s)	愈合情况(例数)				平均愈合时间(d, ±s)
组别	例数	VAS(分，±s)	第4周	第8周	第12周	第16周	平均愈合时间(d, ±s)
京万红软膏组	48	3.09±1.08	0	3	32	45	72.6±16.2
纳米银离子组	48	5.83±1.15	0	1	28	47	69.8±21.3
χ²值	?	?	?	0.26	0.71	0.26	?
t值	?	28.25	?	?	?	?	0.37
P值	?	<0.05	?	0.77	0.45	0.77	0.71

Please choose a citation manager

Content to export